Racial disparities and standard treatment in locally advanced rectal cancer: a National Cancer Database study

Abstract

Nonstandard treatment in stage II and III rectal cancer is associated with worse survival compared to standard treatment regimens. Black patients are more likely to receive nonstandard treatment and have worse survival outcomes compared to White patients.